Benzinga | May 17, 2021 04:29PM EDT

INVO Bioscience Q1 EPS $(0.25) Misses $(0.17) Estimate, Sales $684.52K Beat $590.00K Estimate

INVO Bioscience (NASDAQ:INVO) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.17) by 47.06 percent. The company reported quarterly sales of $684.52 thousand which beat the analyst consensus estimate of $590.00 thousand by 16.02 percent.